Sign In
Buy GWPH
$218.96
+0 (+0%)
At Close: May 27, 2022
GW Pharmaceuticals Stockholders Approve Acquisition by Jazz Pharmaceuticals
07:20pm, Friday, 23'rd Apr 2021
Jazz is about to get the top cannabis-derived drug on the market, in addition to a robust pipeline.
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals
04:01pm, Friday, 23'rd Apr 2021
LONDON and DUBLIN, April 23, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (GW) and Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (Jazz) today announced that GW's shareholders voted to appr
4/20 Holiday Week Had These Cannabis Stocks Fired Up
01:05pm, Friday, 23'rd Apr 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will co
Check Out These 2 Innovative Cannabis Stocks That Are Cornering Hot New Markets
06:27am, Thursday, 22'nd Apr 2021
Marijuana inhalables and edibles aren't the only things on the market anymore.
7 Medical Marijuana Stocks For Your Waiting Room
01:22pm, Tuesday, 20'th Apr 2021
Marijuana stocks may still have some roadblocks until the U.S. market opens, but change is coming, and medical marijuana is leading the way. The post 7 Medical Marijuana Stocks For Your Waiting Room a
GW Pharmaceuticals says its cannabis-based treatment for seizures gets another regulatory green light in Europe
10:42am, Tuesday, 20'th Apr 2021
GW Pharmaceuticals PLC (NASDAQ:GWPH), the medicinal cannabis giant, has received European Commission (EC) approval for the treatment of seizures associated with tuberous sclerosis complex. The EC has
– Tuberous sclerosis complex (TSC) represents a third indication for GW's cannabidiol in Europe –
EPIDOLEX encore presentations highlight long-term safety and efficacy data in patients with tuberous sclerosis complex (TSC) and other treatment-resistant epilepsies
A Cannabis Pro Tells Us Her Hopes for the Medical Marijuana Industry
06:00am, Monday, 12'th Apr 2021
2020 was a big year for the cannabis industry, but 2021 is shaping up to be even bigger.
Healthcare Investors: Here's What You Need to Know About Medical Marijuana
06:15am, Sunday, 11'th Apr 2021
Although research on the medical benefits of the drug is limited in the U.S., we have some ideas about marijuana's ability to disrupt the healthcare industry.
These 2 Stock Market Plays Are Moving Up the Charts in 2021
05:02pm, Wednesday, 07'th Apr 2021
Could these areas see more gains ahead?
Best Performing ETFs of Q1 2021
06:13pm, Tuesday, 06'th Apr 2021
We highlight top performing ETF areas of the first quarter
Actively Managing Cannabis With Tim Seymour (Podcast)
08:00am, Tuesday, 06'th Apr 2021
Actively Managing Cannabis With Tim Seymour (Podcast)
The Benefits of Medical Marijuana, for Patients and Your Portfolio
06:30am, Monday, 05'th Apr 2021
Cannabinoid-based medicines have made major advancements in research and uptake over the past few years.
Why There Could Be at Least 1 More Big Acquisition in the Cannabis Industry This Year
06:00am, Wednesday, 24'th Mar 2021
Multiple high-profile companies may still be on the hunt for a deal.
